List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 28 studies with search of: "Bimatoprost"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: Bimatoprost 0.01% ophthalmic solution;   Drug: Bimatoprost 0.015% formulation 1 ophthalmic solution;   Drug: Bimatoprost 0.015% formulation 2 ophthalmic solution;   Drug: Bimatoprost 0.02% ophthalmic solution;   Drug: Bimatoprost 0.03% ophthalmic solution
2 Completed Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: Bimatoprost 0.01% Ophthalmic Solution;   Drug: Bimatoprost 0.03% Ophthalmic Solution;   Drug: Bimatoprost Vehicle Ophthalmic Solution
3 Recruiting The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye
Conditions: Glaucoma;   Periocular Skin Pigmentation Changes
Interventions: Drug: Latanoprost;   Drug: Bimatoprost;   Drug: Travoprost
4 Active, not recruiting Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study
Condition: Glaucoma, Angle-Closure
Interventions: Drug: Latanoprost-Bimatoprost;   Drug: Bimatoporost-Latanoprost
5 Completed Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-Weeks, Masked Evaluator, Phase IV Multi-Center Study in the US
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: latanoprost 0.005% ophthalmic solution;   Drug: Travoprost 004% sterile ophthalmic solution;   Drug: Bimatoprost .03% sterile ophthalmic solution
6 Active, not recruiting Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Latanoprost (Xalatan);   Drug: Bimatoprost (Lumigan)
7 Completed 24-Hour Intraocular Pressure (IOP) Control With the Bimatoprost/Timolol Fixed Combination
Condition: Glaucoma
Interventions: Drug: Drug: bimatoprost/timolol fixed combination AM or PM;   Drug: Drug: bimatoprost/timolol fixed combination PM
8 Active, not recruiting Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension
Conditions: Ocular Hypertension;   Glaucoma
Interventions: Drug: bimatoprost 0.03% eye drops;   Drug: latanoprost 0.005% eye drops
9 Completed Eyelash Growth From Application of Bimatoprost in Gel Suspension to the Base of the Eyelashes
Condition: Eyelash Lengthening
Intervention: Drug: Bimatoprost mixed with Gonak into a gel suspension
10 Completed
Has Results 		Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%
Conditions: Glaucoma;   Ocular Hypertension
Interventions: Drug: bimatoprost 0.03% eye drops;   Drug: travoprost 0.004% eye drops
11 Completed A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension
Condition: Glaucoma
Intervention: Drug: Bimatoprost
12 Completed Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence
Condition: Eyelashes
Interventions: Drug: Bimatoprost 0.03% sterile solution;   Drug: vehicle sterile solution
13 Completed Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous.
Condition: Cataract
Intervention: Drug: Bimatoprost 0.03%
14 Active, not recruiting Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-Angle Glaucoma (OAG)
Conditions: Open-Angle Glaucoma;   Ocular Hypertension
Intervention: Drug: bimatoprost 0.03%, latanoprost 0.005%, and travoprost 0.004%
15 Completed Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost
Condition: Glaucoma
Intervention: Drug: Bimatoprost 0.03%, Latanoprost
16 Completed Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%
Condition: Glaucoma
Intervention: Drug: Bimatoprost 0.03%, Travoprost 0.004%
17 Completed Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension
Condition: Glaucoma
Intervention: Drug: Bimatoprost 0.03%, Travoprost 0.004%, Timolol 0.5%
18 Recruiting Safety and Efficacy of a Glaucoma Drug Delivery System
Conditions: Glaucoma, Open-Angle;   Ocular Hypertension
Interventions: Drug: bimatoprost;   Drug: bimatoprost;   Device: punctal plug
19 Recruiting Safety and Efficacy of AGN 210699 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma
Conditions: Ocular Hypertension;   Glaucoma
Interventions: Drug: AGN 210669 non-preserved ophthalmic solution;   Drug: AGN 210669 non-preserved ophthalmic solution;   Drug: AGN 210669 non-preserved ophthalmic solution;   Drug: AGN 210669 vehicle ophthalmic solution;   Drug: bimatoprost ophthalmic solution
20 Completed Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues
Conditions: Open Angle Glaucoma;   Ocular Hypertension
Interventions: Drug: Bimatoprost 0.03%;   Drug: travaprost 0.004%;   Drug: latanoprost 0.005% eye drops

Previous Page Studies Shown (1-20) Next Page (21-28)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services